Crossmark

Renal replacement therapy in the neonatal intensive care unit: balancing neonatal expertise with practicality — Proceedings from the First International Neonatal Nephrology Symposium

Crossref DOI link: https://doi.org/10.1038/s41390-025-04478-z

Published Online: 2025-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schwartz, Samantha R.

Vuong, Kim T.

Obregon, Evelyn

Marlais, Matko

Starr, Michelle

Askenazi, David
License Information

Text and Data Mining valid from 2025-10-03

Version of Record valid from 2025-10-03
More Information

Article History

Received: 17 August 2025

Accepted: 30 August 2025

First Online: 3 October 2025

Competing interests

: All authors report no real or perceived conflicts of interest that could affect the study design; collection, analysis and interpretation of data; the writing of the report; or the decision to submit the manuscript for publication. For full disclosure, we provide the additional list of authors’ other commitments and funding sources that are not directly related to this study. Dr. Askenazi consults for Nuwellis and Seastar. He is Chief Scientific Officer of Zorro-Flow Inc. He has invention rights for urine collection and fluid balance systems.

Document is current

Any future updates will be listed below